Wells Fargo’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.94M Buy
340,565
+138,602
+69% +$599K ﹤0.01% 3635
2026
Q1
$782K Sell
201,963
-124,389
-38% -$510K ﹤0.01% 3884
2025
Q4
$1.36M Buy
326,352
+132,492
+68% +$513K ﹤0.01% 3726
2025
Q3
$638K Buy
193,860
+33,231
+21% +$93.8K ﹤0.01% 4120
2025
Q2
$228K Buy
160,629
+14,173
+10% +$20.1K ﹤0.01% 4700
2025
Q1
$218K Buy
146,456
+31,898
+28% +$50.2K ﹤0.01% 4643
2024
Q4
$128K Buy
114,558
+12,285
+12% +$10.5K ﹤0.01% 5059
2024
Q3
$96.9K Sell
102,273
-2,271
-2% -$2.87K ﹤0.01% 5042
2024
Q2
$165K Buy
104,544
+7,313
+8% +$10.6K ﹤0.01% 4635
2024
Q1
$141K Sell
97,231
-1,358
-1% -$1.95K ﹤0.01% 4685
2023
Q4
$132K Buy
98,589
+8,025
+9% +$9.43K ﹤0.01% 4734
2023
Q3
$129K Sell
90,564
-14,378
-14% -$20.4K ﹤0.01% 4629
2023
Q2
$121K Buy
104,942
+30,677
+41% +$36.2K ﹤0.01% 4917
2023
Q1
$78.7K Buy
74,265
+12,428
+20% +$17.9K ﹤0.01% 4935
2022
Q4
$94K Sell
61,837
-87,469
-59% -$150K ﹤0.01% 4565
2022
Q3
$317K Sell
149,306
-387
-0.3% -$816 ﹤0.01% 3972
2022
Q2
$200K Buy
149,693
+37,426
+33% +$55.5K ﹤0.01% 4280
2022
Q1
$237K Sell
112,267
-53,086
-32% -$129K ﹤0.01% 4888
2021
Q4
$613K Sell
165,353
-316,424
-66% -$1.36M ﹤0.01% 4505
2021
Q3
$2.4M Buy
481,777
+90,150
+23% +$519K ﹤0.01% 3498
2021
Q2
$2.55M Buy
391,627
+38,124
+11% +$266K ﹤0.01% 3466
2021
Q1
$2.44M Buy
353,503
+116,571
+49% +$985K ﹤0.01% 3521
2020
Q4
$2.42M Buy
236,932
+12,543
+6% +$81.3K ﹤0.01% 3358
2020
Q3
$785K Sell
224,389
-43,844
-16% -$208K ﹤0.01% 4039
2020
Q2
$1.34M Buy
268,233
+108,287
+68% +$368K ﹤0.01% 3585
2020
Q1
$545K Sell
159,946
-19,848
-11% -$85.7K ﹤0.01% 3969
2019
Q4
$985K Buy
179,794
+8,347
+5% +$47K ﹤0.01% 3867
2019
Q3
$981K Buy
171,447
+3,939
+2% +$26.8K ﹤0.01% 3851
2019
Q2
$1.28M Sell
167,508
-4,172
-2% -$22.5K ﹤0.01% 3701
2019
Q1
$903K Buy
171,680
+33,488
+24% +$232K ﹤0.01% 3952
2018
Q4
$903K Sell
138,192
-19,539
-12% -$219K ﹤0.01% 3915
2018
Q3
$2.72M Sell
157,731
-37,483
-19% -$557K ﹤0.01% 3149
2018
Q2
$2.72M Buy
195,214
+33,125
+20% +$559K ﹤0.01% 3212
2018
Q1
$2.48M Buy
162,089
+51,356
+46% +$734K ﹤0.01% 3208
2017
Q4
$1.28M Sell
110,733
-7,729
-7% -$115K ﹤0.01% 3752
2017
Q3
$2.25M Buy
118,462
+14,333
+14% +$295K ﹤0.01% 3202
2017
Q2
$2.51M Sell
104,129
-4,717
-4% -$103K ﹤0.01% 3028
2017
Q1
$2.16M Sell
108,846
-24,025
-18% -$536K ﹤0.01% 3143
2016
Q4
$3.2M Buy
132,871
+17,361
+15% +$483K ﹤0.01% 2765
2016
Q3
$3.21M Sell
115,510
-271,575
-70% -$7.18M ﹤0.01% 2610
2016
Q2
$9.44M Buy
387,085
+136,066
+54% +$3.86M ﹤0.01% 1876
2016
Q1
$8.43M Sell
251,019
-25,487
-9% -$802K ﹤0.01% 1942
2015
Q4
$8.26M Buy
276,506
+85,521
+45% +$2.88M ﹤0.01% 1981
2015
Q3
$6.02M Sell
190,985
-10,564
-5% -$515K ﹤0.01% 2193
2015
Q2
$9.74M Buy
201,549
+44,762
+29% +$1.89M ﹤0.01% 1939
2015
Q1
$6.8M Sell
156,787
-33,353
-18% -$1.2M ﹤0.01% 2172
2014
Q4
$5M Buy
190,140
+20,292
+12% +$445K ﹤0.01% 2342
2014
Q3
$3.02M Buy
169,848
+9,400
+6% +$192K ﹤0.01% 2708
2014
Q2
$3.85M Buy
160,448
+5,368
+3% +$109K ﹤0.01% 2523
2014
Q1
$3.9M Buy
155,080
+46,690
+43% +$1.29M ﹤0.01% 2497
2013
Q4
$2.47M Buy
108,390
+4,793
+5% +$96.8K ﹤0.01% 2779
2013
Q3
$2.35M Buy
+103,597
New +$2.39M ﹤0.01% 2778

Other funds holding PGEN

Wells Fargo's PGEN Position: Q2 2026 in Review

Wells Fargo increased its Precigen (PGEN) stake by 69% in Q2 2026, buying an estimated $599K and bringing the position to 340,565 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #3635.

Wells Fargo first reported a position in PGEN in Q3 2013 and has held it in 52 quarters since. The position peaked at $9.74M in Q2 2015. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Wells Fargo held 340,565 shares of Precigen worth $1.94M as of Q2 2026.
  • Wells Fargo bought 138,602 Precigen shares in Q2 2026, an estimated $599K.
  • Precigen made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3635 holding.
  • Wells Fargo first reported a position in Precigen in Q3 2013 and has held it in 52 quarters since.
  • Wells Fargo's Precigen position peaked at $9.74M in Q2 2015.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.